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Abstract 
Many neurodegenerative and neuropsychiatric diseases and other brain disorders are 
accompanied by impairments in high-level cognitive functions including memory, attention, 
motivation, and decision-making. Despite several decades of extensive research, neuroscience is 
little closer to discovering new treatments. Key impediments include the absence of validated 
and robust cognitive assessment tools for facilitating translation from animal models to humans. 
In this review, we describe a state-of-the-art platform poised to overcome these impediments and 
improve the success of translational research, the Mouse Translational Research Accelerator 
Platform (MouseTRAP), which is centered on the touchscreen cognitive testing system for 
rodents. It integrates touchscreen-based tests of high-level cognitive assessment with state-of-the 
art neurotechnology to record and manipulate molecular and circuit level activity in vivo in 
animal models during human-relevant cognitive performance. The platform also is integrated 
with two Open Science platforms designed to facilitate knowledge and data-sharing practices 
within the rodent touchscreen community, touchscreencognition.org and mousebytes.ca. 
Touchscreencognition.org includes the Wall, showcasing touchscreen news and publications, the 
Forum, for community discussion, and Training, which includes courses, videos, SOPs, and 
symposia. To get started, interested researchers simply create user accounts. We describe the 
origins of the touchscreen testing system, the novel lines of research it has facilitated, and its 
increasingly widespread use in translational research, which is attributable in part to knowledge-
sharing efforts over the past decade. We then identify the unique features of MouseTRAP that 
stand to potentially revolutionize translational research, and describe new initiatives to partner 
with similar platforms such as McGill’s M3 platform (m3platform.org). 
Keywords: circuits, cognition, collaboration, community building, data sharing, knowledge 
sharing, mouse models, neurodegenerative disease, neuropsychiatric disease, neurotechnology, 
open science, reproducibility, standardization, touchscreens, translation  
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Introduction 
Many neurodegenerative, neuropsychiatric and other brain disorders are accompanied by 
impairments in high-level cognitive functions including memory, attention, motivation and 
decision-making. Patients with these disorders may have difficulty dividing, switching or 
maintaining attention, remembering persons, objects and locations or modifying their behaviour 
when appropriate. They thus may be unable to care for themselves, complete even the simplest 
everyday tasks and maintain meaningful interpersonal relationships. These diseases contribute to 
a severely diminished quality of life for these patients and their caregivers. Effective treatments 
for them are desperately needed.  
Despite several decades of extensive research to identify the neural mechanisms that 
underlie functional impairments in brain disorders and the establishment of several 
interdisciplinary initiatives aimed at propelling translational research forward, neuroscience is 
little closer to discovering new treatments. On the one hand, the lack of progress is surprising 
given the recent rise in revolutionary new tools for intervening in and visualizing neural circuit 
activity in vivo in animal models and the development of next generation mouse models that bear 
greater genetic and functional similarity to the human diseases they are designed to model. On 
the other hand, the current lull in discovery is perhaps unsurprising, for several reasons. First, 
until fairly recently, cognitive testing tools for reliably and comprehensively assessing high-level 
cognitive functions and disease-related cognitive impairments in mice were not available. 
Second, despite the enormous quantity of data that translational research has produced, pre-
publication knowledge and data sharing are not common practices, and rodent behavioral 
paradigms are still considered to lack robustness. Third, although developing and testing novel 
therapies for cognitive impairments requires reproducibility, it is uncommon for rodent 
behavioral researchers to standardize their research practices in ways that facilitate comparison 
of findings across labs and thus advance mechanistic discovery.  
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 As we explain in this review, this situation is rapidly changing, and the use of the 
standardized cognitive testing of rodents is on the rise.1 The rodent touchscreen approach is 
uniquely suited to this application. Touchscreens are being combined with cutting-edge 
visualization and intervention techniques that allow unprecedented access to and control over 
molecular and circuit level activity in vivo in awake behaving animals. Open Science Platforms 
have been created that offer rodent behavioral researchers an unprecedented opportunity to share 
knowledge and technical expertise and to upload, visualize and comparatively analyze their data 
to gain a broader and more detailed understanding of molecular, cellular and circuit-level activity 
in normal and diseased brains. Such developments have the potential to greatly facilitate cross-
species translational research and propel forward mechanistic and therapeutic discovery. 
We begin by identifying a set of widely agreed upon benchmarks for translational 
research. We then explain how, during the past three decades, researchers have sought to meet 
these benchmarks by developing, validating, and using novel touchscreen-based testing methods. 
We go on to describe the newly-minted Mouse Translational Research Accelerator Platform 
(MouseTRAP), which is centered on the touchscreen testing system and highlight its distinctive 
features. MouseTRAP is a service platform that operates within the Rodent Cognition Core at 
Western University and combines the use of our touchscreen-based system with cutting-edge 
neurotechnology that allows molecular and circuit-level activity to be measured and manipulated 
with millisecond precision in the brains of healthy mice and mouse models of disease during 
human-relevant cognitive performance. Another important feature that sets MouseTRAP apart is 
its integration with two novel Open Science platforms, touchscreencognition.org and 
mousebytes.ca., which are designed to facilitate knowledge and data sharing within the rodent 
touchscreen community. We end by describing new initiatives to partner with similar platforms 
such as McGill’s M3 platform (m3platform.org).  
 
Benchmarks for translational cognitive neuroscience research  
In the first two decades of the 21st century, several major initiatives were established in order to 
fast-track the development of treatments for cognitive impairments in neuropsychiatric and 
neurodegenerative disorders. Representative examples include Cognitive Neuroscience 
Treatment Research to Improve Cognition in Schizophrenia (CNTRICS),2,3 NEWMeds4, the US 
National Institute of Health’s Toolbox (NIH Toolbox)5,6 and the US National Institute of Mental 
Health’s Research Domain Criteria Project (NIMH RDoC).7,8 These initiatives have variously 
brought together preclinical translational behavioral neuroscientists, clinical researchers, 
cognitive neuroscientists working with humans and/or animal models, systems neuroscientists 
and members of the pharmaceutical industry with an aim to (a) develop more representative 
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mouse models of neurodegenerative and neuropsychiatric disease, (b) improve tools for the 
assessment of cognition in humans and mice, and (b) increase the similarity of tools used for the 
behavioral assessment of cognitive functions across researchers and species. These initiatives 
have prompted researchers to make explicit a number of desirables for cognitive assessment 
tools used in translational research.  
 First, a primary hurdle to translating results from rodent to human behavioral studies, 
which we have emphasized in our previous work, is the mismatch between tools used to assess 
cognition in rodents and humans. There is now widespread agreement that the more similar the 
tasks for assessing cognition are across species (face validity), the more likely it is that the same 
cognitive functions and neural circuits will be involved. But even if tasks used to probe cognitive 
functions in different species appear roughly similar, it is a separate question whether they are 
suitable for individuating cognitive capacities (construct validity) and identifying the neural 
circuits that mediate task performance (neurocognitive validity).9 Achieving construct validity is 
widely understood to be an iterative process, as findings from exploratory and hypothesis-driven 
experiments often prompt task refinement and/or construct revision. Construct validity may be 
enhanced by good task design that includes, for example, parametric manipulation of variables 
that load on the construct of interest, such as delay/retention intervals to test for delay-dependent 
effects that can be interpreted as changes in memory, and manipulations of stimulus detectability 
to study attention.10,11  
 Translational researchers must also establish the construct and neurocognitive validity of 
cognitive assessment tools across species. Translational neurocognitive validity9 is essential for 
determining if the same circuits are involved in task performance across species. Ideally, 
translational researchers want to be able to predict that a treatment that works in rescuing a 
cognitive deficit in a rodent model of disease will be effective in rescuing that deficit in human 
clinical populations (translational predictive validity). Cognitive assessment tools should also be 
sensitive to dose-dependent effects of drugs on cognitive abilities, so as to increase the likelihood 
that a drug that improves cognition in a rodent model has a greater chance of having a positive 
impact in the human case. Achieving translational neurocognitive validity is also an iterative 
process, as it requires investigators working in human and non-human animal cognition to toggle 
back and forth between human and rodent tasks to refine them in order to facilitate translation 
while ensuring that other dimensions of validity are maintained.3,9 
 Reproducible results are also essential. One hurdle to progress in translational research is 
a historical lack of emphasis on replicating results and a failure to standardize cognitive 
assessment tools across research groups. In human and animal cognitive studies, although 
different research groups might use the same cognitive task or assessment tool for investigating a 
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cognitive capacity (e.g., working memory), features of the overarching and specific protocols 
associated with use of that tool (e.g., types of stimuli used, intertrial intervals, investigator 
interactions with participants) commonly vary across research groups. Yet even subtle 
differences in protocols could potentially result in subtle differences in the cognitive processes 
and underlying neural mechanisms being investigated. Lack of standardization is a problem.  
It is not enough to detect effects in a single lab; ideally we want many labs to run the 
same experiments in order to determine whether effects observed in a single lab are real or 
chimerical. It is thus fundamental to have a different investigator working in a different research 
context run the same experiment, following the exact same protocol. If another group of 
scientists can use an experimental design, paradigm, protocol and statistical analysis techniques 
and obtain similar results as in another research study, it increases confidence that the findings 
are not idiosyncratic to a specific experimental context. This is why methodological and data 
transparency in the form of Open Science initiatives and on-line platforms and collaborative 
work across laboratories to directly replicate experiments (adhering to the same standards of 
reliability that were upheld in the original research study) is so important. It is especially 
important in translational research, given that determining the efficacy of a drug for treating 
cognitive impairments requires pre-clinical trials in rodents, across which results must be 
replicated before moving to human clinical trials, which also require replication.  
It is worth emphasizing that meeting the aforementioned benchmarks is not possible in a 
single laboratory or research study; it instead requires an unprecedented amount of collaboration 
and coordination of research practices within and across research groups working at different 
levels of analysis and with different species and consisting of investigators with diverse 
theoretical backgrounds and technical expertise.12 It also takes a significant amount of resources 
and time to gradually hit each of these benchmarks to reach the point at which discovery of novel 
therapeutics is possible.  
Our aim in the rest of this paper is to describe how we have sought to meet these 
benchmarks for translational research using the touchscreen cognitive testing method and 
initiatives based on this approach.  
 
The Touchscreen Approach to Cognition: From Non-human primates to humans to 
rodents and beyond 
Nearly two decades prior to the establishment of the CNTRICS, NewMeds and RDoC 
initiatives, a group of neuropsychologists at Cambridge University developed a suite of 
computerized touchscreen-based tasks, the Cambridge Neuropsychological Test Automated 
Battery (CANTAB), in order to develop cognitive profiles for patients with neurodegenerative 
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diseases. While other cognitive testing batteries were available, what set CANTAB apart was the 
emphasis Cambridge researchers placed on translational potential of the battery. At that time, 
there was a heated debate about whether observed structure-function differences across species 
were attributable to differences in the cognitive tools used to assess cognitive functions across 
species or to bona fide structure-function differences.13,14,15,16 In non-human primate tasks that 
were used to assess working memory, attention, and planning, monkeys were presented with 
visual stimuli on a computer screen and were required to select the correct stimulus with a finger 
press and received positive feedback for accurate responses. Cambridge researchers modeled 
CANTAB tasks after these non-human primate tasks (and vice-versa) based on the rationale that 
the more similar cognitive tasks are across species (face validity), the greater the likelihood that 
the same cognitive processes and underlying neural mechanisms will be involved in performance 
on those tasks (i.e., neurocognitive validity). While increasing the face validity of cognitive tasks 
across species does not guarantee that the cognitive functions and neural mechanisms involved in 
task performance will be identical (see discussion above), it is arguably one of the best heuristics 
researchers have to increase the likelihood that they will be.  
The development of the CANTAB task battery also was shaped by a concern for 
construct validity—or what researchers described as a careful componential analysis of the 
cognitive functions of memory, attention and planning into their sub-component processes. Each 
task was developed with an eye towards precisely individuating and measuring deficits in the 
cognitive function it was designed to measure.  
The touchscreen task battery approach was also regarded as having certain advantages 
with respect to reliability over other approaches to assessing cognition. Ensuring that stimuli, 
required responses on the part of the subject and feedback are consistent across tasks and 
conditions, allows potential confounds to be ruled out when subject performance across tasks in 
the battery are compared. Because the tests are automated, they can be used to measure 
behavioral response latencies with milli-second accuracy, increasing the sensitivity of the tasks 
for the detection of cognitive impairments. Although a test administrator must be present to 
explain and supervise the tests, automation also decreases the possibility of certain kinds of 
confounds that may occur as a result of interactions between scientists and their subjects during 
the course of an experiment, thus increasing reliability.  
The CANTAB testing battery was originally used to characterize cognitive impairments 
in persons with Alzheimer-type dementia and Parkinson’s disease.17,18, 19 It has since been used 
to assess cognition in a number of conditions including Attention Deficit Disorder, Autism 
Spectrum Disorder, Depression and Affective Disorders, Huntington’s disease and 
Schizophrenia. CANTAB tests have been shown to have predictive validity with respect to 
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cognitive decline in persons with neurodegenerative disorders. Tests from the battery also have 
been used in the context of neuroimaging studies to illuminate the neural substrates underlying 
cognitive deficits in patients with neurodegenerative and neuropsychiatric diseases and to assess 
the impact of certain drugs on task performance. Today, the tests are the most widely used 
computerized measures of cognition in humans, 
(https://www.cambridgecognition.com/cantab/cognitive-tests/) and computerized training 
batteries also are regarded as promising tools for improving cognition in persons with 
neuropsychiatric, neurodegenerative and other brain disorders (e.g., concussion). One example of 
a computerized training battery, CogMed20,21 is aimed at improving working memory and 
attention in persons with neurodevelopmental disorders and/or intellectual disabilities 
(https://www.cogmed.com).  
In the 1990s, the researchers who developed CANTAB were optimistic that the battery, 
when used in combination with imaging techniques, would “yield a wealth of data correlating 
structure and function.”22 Yet, developing treatments for human cognitive dysfunction requires 
tools for intervening in the brain and assessing cognition in non-human animals, and at 
Cambridge in the early 1990s the drive to develop computerized touchscreen-based tasks for 
rodents began. At that time, the predominant tasks used to investigate cognition, cognitive 
impairments and their neural underpinnings in rodents included mazes (e.g., Morris water maze), 
foraging and associative learning tasks (e.g., fear conditioning). Although these tasks shed some 
light on the mechanisms of cognition in the mammalian brain, differences in task type, task 
parameters and stimuli used to assess cognition in rodents compared to humans were obstacles to 
relating more precise findings about cognitive functions across species. So, too, was the fact that 
many of these tasks were aversively motivated, making stress a potential confound. Moreover, 
the kinds of high-level cognitive functions that are impaired in human neurodegenerative and 
neuropsychiatric diseases, for which experiments with CANTAB had already provided evidence, 
outstripped the types of cognitive functions that could be assessed in rodents using conventional 
methods. What were needed were tests to behaviorally assess rodent cognition that involved 
cognitive functions similar to those shown to be impaired in humans with neurodegenerative and 
neuropsychiatric disease. Additionally, there was no reason to think that rodents were incapable 
of more complex forms of cognition of the kind being tested by means of computerized 
touchscreen based visual tasks in humans and non-human primates, only skepticism that rodents, 
given their relatively poor vision, would respond to visual stimuli presented on a computer 
screen.  
Despite such skepticism, it had been noted that when rats were placed into pigeon 
touchscreen operant chambers, “[they were] able to respond and attend to [. . .] computer graphic 
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stimuli presented on a touch-sensitive screen”.23 This initial discovery spurred the publication of 
the first computerized automated rodent operant touchscreen apparatus at Cambridge in 199423 
(another group introduced a pressure-sensitive touch window apparatus that same year24), a 
similar apparatus for testing mice and mouse models of neurodegenerative and neuropsychiatric 
disorders in 200125, and the later development of a modified version of the apparatus that can be 
used in combination with novel intervention (e.g., DREADDS, optogenetics) and visualization 
(e.g., fiber photometry, miniscopes) techniques to intervene in and observe brain activity in vivo 
while rodents perform cognitive tasks.  
The development of the rodent touchscreen cognitive testing platform sought to achieve 
face validity with respect to human tests such as those in the CANTAB battery in order to 
facilitate the translation of findings from rodents to humans. Rodent touchscreen-based tasks 
involve visual stimuli that are presented on a touch-sensitive screen, similar to human 
touchscreen tasks. Rodents respond directly to visual stimuli with nose-pokes, and positive 
reinforcers such as strawberry milkshake or food pellets are delivered for correct choices, much 
like human subjects receive positive visual feedback and monkeys receive food rewards on 
touchscreen tasks when they make a correct choice with a finger press.  
Touchscreens have a number of important advantages that have been noted previously, 
and in a number of articles in this special issue of Genes, Brains, and Behavior.26 First, in 
common with some other methods such as standard operant chambers, the tasks are automated, 
providing accuracy of task parameters and measures, and eliminating experimenter errors that 
are characteristic of more conventional techniques in which animals and testing materials such as 
stimuli often undergo extensive handling during testing. It is also non-aversive compared to other 
tasks used to assess rodent cognition. This is particularly important as experiments can easily be 
confounded by the physiological changes that an animal undergoes due to stress caused by cool 
water, electric shock or head fixation.27,28,29 Another advantage is that, compared to tasks like the 
Morris Water Maze and contextual fear-conditioning, touchscreens readily may be used to assess 
cognitive impairments in disabled and motorically impaired animals.30 The touchscreen method 
is also high-throughput; automation allows an investigator to run many touchscreen experiments 
simultaneously. Infrared beams and video tracking devices that are used to monitor an animal’s 
behavior while performing in the apparatus also provide a wealth of data that may be probed 
using different data analysis techniques. And unlike other behavioural phenotyping approaches, 
all tests feature the same test setting, stimuli, responses, and reinforcers, allowing comparison 
across test unconfounded by changes in the basic methodology.  
During the past two decades, rodent touchscreens have been at the center of a number of 
ongoing lines of research. Importantly, a number of optimization and validation studies have 
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been undertaken to systematically determine the kinds of task parameters that may impact 
learning in the apparatus.31 In one research study, one set of experiments was aimed at 
determining whether rats have biases for certain touchscreen visual stimuli, which might account 
for task performance and negatively impact learning in the apparatus.31 Another set was aimed at 
determining the optimal stimulus size for performance in the apparatus.31 Other experiments 
sought to determine the impact of inter-trial intervals, trials per session and trial initiation 
requirements on learning with an eye towards selecting optimal parameters for learning.31 
Additional studies have included research to determine whether there are differences in 
performance on touchscreen-based tasks across different mouse strains, the role that stressors 
have on different strains32 and the role of reinforcer type and strength on learning in 
touchscreens.33,34 Touchscreen researchers also have sought to determine if sex differences 
impact task performance, which is particularly important for obtaining findings that are 
generalizable from rodents to the human population (i.e., external validity).31,35,36 During the past 
several decades, touchscreen research also has illuminated behavioral differences in task 
performance across species. For example, mice tend to be less impulsive in the touchscreen and 
so better at tasks in which they have to withhold responding (e.g., 5-choice and CPT (See Table 
1 for relevant citations)). In fact, the rat touchscreen apparatus has an additional ’shelf’ to slow 
the rats down and speed learning (Bussey et al 1994), whereas mice do not need this shelf. 
Exploratory translational research has been directed at developing new touchscreen-based 
tasks for rodents, in some cases using human CANTAB or CANTAB-like tasks as starting points 
and iterating back and forth between human and rodent versions of the tasks in order to achieve 
face validity between the two. Using this strategy, a number of novel touchscreen tasks for rats 
and mice have been developed, including paired-associates learning (PAL)37,38 the location 
discrimination (LD) test of pattern separation39, trial-unique nonmatching-to-location (TUNL), 
the rodent continuous performance task (rCPT)40 and 5-Choice serial reaction time (5-CSRTT) 
to name only a handful. These tasks are components of a testing battery that can be used to study 
a variety of cognitive functions including: reward learning, memory, perceptual discrimination, 
object-place associative learning, attention, impulsivity, compulsivity, extinction, simple 
Pavlovian conditioning, and other constructs.41 This growing battery of tasks was first described 
in 201241,42, became a part of the NEWMEDS initiative in 201543 and has since grown to over 
30 tasks (See Table 1). Given the flexibility of the touchscreen operant platform for developing 
novel behavioral tasks, new tasks are being designed and validated all the time and once a task is 
developed, it may serve as a single behavioral tool for use in a research study or be used as a part 
of the larger testing battery.  
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Using a battery approach, as is done with human CANTAB tasks, also increases the 
reliability of rodent touchscreen experiments. Ensuring that the apparatus, stimuli, required 
responses and reward are consistent across tasks and conditions, allows these potential 
confounds to be ruled out when a rodent’s performance across tasks in the battery is compared. 
For example, if an animal fails an object-place paired associative learning task but performs well 
on visual discrimination and reversal, it is unlikely that the paired associate learning impairment 
is due to a difficulty with perceptually discriminating objects or generalized deficit in learning 
ability. A major advantage of the battery approach is that it can be used to provide a cognitive 
profile of an animal model of disease and to identify rescuable deficits that can serve as the focus 
of drug testing. Touchscreens have been used to characterize cognitive impairments in a number 
of rodent models of neurodegenerative and neuropsychiatric disease including models of 
Huntington’s disease,44 addiction,45 Alzheimer’s Disease46,47 to name only a few. 
Another advantage of the touchscreen system is that it has and continues to evolve in line 
with the latest developments in neurotechnology and mouse models of disease.  To date, 
touchscreen-based tasks have been used in combination with in vivo electrophysiology, 
optogenetics, fiber photometry and miniscopes to measure neural activity during task 
performance and to assess the impact of in vivo causal interventions. Findings from such 
experiments may be compared to findings from non-invasive imaging experiments in healthy and 
clinical human populations as a means to determine if homologous structures, circuits, cell 
populations and molecules are implicated in cognition and cognitive impairments across species.  
A major goal of the touchscreen approach is to facilitate translation from animal models 
of disease to the human diseases they are designed to model. In a proof-of-concept study, 
touchscreen researchers established that the performance of transgenic mice and humans with a 
homologous gene deletion performed similarly on an object place paired associates learning 
task.48 In other studies, selective vigilance decrements in the 5-CSRTT were rescued by 
anticholineasterase in a mouse model of Alzheimer’s disease, mirroring rescue of the same 
vigilance impairment on the same task by the same class of drug in Alzheimer’s patients.49,50,51 
More recently, a touchscreen-based progressive ratio task was used to establish that levels of 
motivation in an animal model of Huntington’s disease (R6/1 mice) were comparable to 
Huntington’s disease patients’ motivational levels on a similar touchscreen-based version of the 
task.52  In addition, numerous studies highlight the similarity of findings across species on 
touchscreen tests of reversal learning (a test of cognitive flexibility).9,53 
Consistent with the recognition by CNTRICS, NEWMEDS, the NIH Toolbox and RDoC 
that standardization of cognitive assessment tools is fundamental for driving translational 
research forward, touchscreen users have collaborated to develop standardized protocols for 
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rodent touchscreen tasks. The Bussey-Saksida touchscreen system was commercialized in 2009 
in response to increasing demand for access to the technology. Then, in 2013, Bussey, Saksida 
and colleagues published three invited papers in Nature Protocols, that contain detailed step-by-
step instructions on how to prepare animals for pre-training in the apparatus, how to pretrain and 
train the animals and how to analyze the behavioral data. Also included are instructions on how 
to trouble-shoot in response to any issues that may arise.54,55,56 (See also a protocol paper for PR 
test of motivation/apathy published separately.57)  
It is relevant to note that these published protocols were the culmination of two decades 
of research to ensure the reliability and validity of the touchscreen cognitive testing method for 
rodents and the knowledge and insights gained during this process. The transparent sharing of 
methods, which was unique in so far as it predated recent calls for Open Science, afforded the 
possibility that other researchers could more readily implement the method in their own 
laboratories. These publications have also laid the groundwork for standardizing the touchscreen 
cognitive testing method across laboratories so that touchscreen experiments may be directly 
replicated, ultimately leading to more powerful discoveries. Indeed, use of the rodent 
touchscreen system has grown exponentially in the past two decades. In 2012, there were 
roughly 30 labs using the technology26; now, in 2020, over 300 different research groups in more 
than 200 research institutes in at least 26 countries are using the technology. Moreover, there has 
been a rapid and sustained increase in touchscreen publications over the last two decades (from 
about 5 per year in 2005 to over 40 in 2018).58  
 Our aims in the rest of the paper are to describe recent state-of-the-art research at 
Western University combining the use of touchscreens with cutting-edge neurotechnology and 
open science platforms, and some similar exciting developments occurring in laboratories at 
other institutions.   
 
New Frontiers in Translation: The Mouse Translational Research Accelerator Platform 
(MouseTRAP) 
There is currently a pressing need to identify new approaches to developing more 
effective and specific treatments for cognitive impairments that accompany many 
neuropsychiatric, neurodegenerative and other brain disorders. One approach that holds great 
promise is to understand how dysfunctions in the molecular and cellular underpinnings of the 
brain impact those aspects of cognition—including memory, attention and cognitive flexibility—
that are so profoundly affected in these disorders. Key to the success of this approach are tools 
that allow the assessment of cognition in animal models of disease in a way that is directly 
relevant to humans and that may be paired with cutting-edge neurotechnologies that allow 
neuronal, glial, and neurochemical activity to be manipulated and recorded with millisecond 
precision during cognitive assessment. This integrative approach may be used to determine 
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which neural circuits underlie which aspects of cognition and to identify disruptions in neural 
circuitry that correlate with cognitive impairments. Therapeutic interventions that directly target 
these neural circuits may then be tested for efficacy in improving cognitive performance in 
animal models. Importantly, the success of this approach requires careful cognitive assessments 
of mouse models of disease in order to develop rigorous cognitive profiles that may then be 
directly compared to cognitive profiles of human patients they are designed to model, and that 
can be used to ground assessments of the potential efficacy of candidate therapeutic 
interventions.  
MouseTRAP is a technologically innovative and methodologically integrative service 
platform operating out of the Rodent Cognition Core (RCC) at Western University that aims to 
realize this circuit-based approach to developing effective and specific treatments for brain 
disorders. The MouseTRAP platform features the largest collection of mouse touchscreens in the 
world, a wide range of animal models of neurodegenerative, neuropsychiatric and other brain 
disorders (e.g., concussion) and cutting-edge neurotechnologies for recording or manipulating 
neuronal, glial, and neurochemical activity with millisecond precision in animal models of 
disease during human-relevant cognitive performance.  
MouseTRAP researchers are committed to the idea that open, accessible, and 
reproducible science is key to accelerating discovery in translational research. Given that the 
costs associated with implementing touchscreen technology may be prohibitive for some 
researchers, MouseTRAP democratizes access to these tools by offering academic and industry 
scientists varying levels of research support at different rates. MouseTRAP researchers can 
conduct a full touchscreen-based cognitive assessment in a mouse model of disease, provide 
researchers with training and access to state-of-the art equipment to run their own experiments 
on-site or offer them technical guidance to implement MouseTRAP tools in their own 
laboratories. In addition, interested researchers from around the globe also may take advantage 
of extensive knowledge and data-sharing resources available on two web-based science 
platforms that are integrated with MouseTRAP, touchscreencognition.org and mousebytes.ca.  
Our aims in the rest of the paper are to describe in detail the distinctive features of 
MouseTRAP and the research it facilitates.  
 
Developing Complementary Touchscreen Cognitive Assessment Tools for Rodents & Humans 
The development of next-generation mouse models that bear greater genetic and 
functional similarity to their human patient counterparts provide a novel opportunity to use the 
touchscreen cognitive testing battery to provide cognitive profiles for these animals. These 
profiles may then be directly compared to the performance profiles of their human patient 
counterparts on a similar or nearly identical battery of touchscreen tests. MouseTRAP currently 
enables high-throughput assessment of cognition in up to 500 mice per day on more than 20 
different cognitive tests developed by the Western team. Since the inception of the platform 2 
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years ago, 56 active phenotyping projects by 65 researchers have or are currently being 
undertaken using the platform. 
Researchers working with animal models of neurodegenerative and neuropsychiatric 
disease affiliated with the CFREF-funded BrainsCAN Rodent Cognition Core at Western 
(https://brainscan.uwo.ca/research/cores/rodent_cognition_core/index.html), where about 100 
touchscreens are currently housed are, in collaboration with researchers in Western’s Imaging 
Core and researchers at Lawson Health Research Institute, iteratively developing a suite of tests 
that are adequately parameterized for rodents and humans. This comparative approach will 
enable researchers to determine the translational neurocognitive and predictive validity of the 
tests, as has been done in previous studies for animal models of schizophrenia, Huntington’s 
disease, and Alzheimer’s disease mentioned in the previous section. To ensure that the tests 
remain cutting edge, new tests are being developed and validated with emphasis on combining 
appropriate tests with mouse disease models.   
 
The advantage of using mouse models  
Rodents are critical subjects for understanding causal relationships between molecular 
and circuit changes affecting cognitive function. They serve as one of the initial lines of enquiry 
in the quest to understand cognition in mammals, and can provide knowledge that can be taken 
forward to inform experiments in other species, such as non-human primates and humans. 
Although touchscreens for rodents were initially developed for rats, the availability of mouse 
touchscreens combined with the power of genetically modified mice has substantially multiplied 
the possibilities for translational rodent behavioral research (MouseTRAP is expanding to 
include rat experiments and mousebytes.ca (described below) accommodates the inclusion of 
data from rats). 
Recent developments of genetic techniques have diversified genetic manipulations to 
multiple species, but mice remain the species of choice. In addition to being less expensive to 
maintain than rats, the sheer number and diversity of genetically-modified mice allows 
researchers to manipulate almost any neuronal circuit, by using a combination of floxed (flanked 
by lox P)-engineered mice, Cre recombinase mice, viral vectors and other intersectional genetic 
strategies.59,60 Thanks to multiple technological developments, including the use of CRISPR/Cas 
and viral technology, new viral vectors can be injected in the periphery to target specific groups 
of brain cells.61,62. An extensive description of all of these different technologies is beyond the 
scope of the present review, but we will briefly summarize how the use of these technologies 
combined with high-level cognitive testing using touchscreens can reveal subtle and specific 
roles of genes and circuits in high-level cognition.  
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One gene recombination strategy is gene knock-out, which involves the replacement or 
elimination of genes to understand how loss of function or specific mutations affect cognition. 
Knockout of genes, specifically knockout of neurotransmitter receptors, metabolic enzymes and 
transporters, has been used extensively to provide information on the role of genes and gene 
products in behavior. Unfortunately, it is sometimes difficult to discern with constitutive 
knockouts if phenotypes are related to altered brain development. Moreover, if a gene is 
expressed in multiple brain regions or cellular types, it can be difficult to relate specific 
phenotypes to changes in genotype. Many of these limitations, however, can be ameliorated 
through the use of approaches such as Cre/lox technology, which allows for knockout or 
knockdown of genes in specific brain regions, cell types or in specific time windows, by using 
inducible and brain-region or cell-type specific promoters. This can be achieved either via a 
breeding strategy using Cre mouse lines, or via viral vectors expressing Cre. Viruses can be 
stereotaxically injected at specific ages and in specific brain regions, thus restricting the temporal 
and anatomical expression of the transduced gene. Cre mice can also be used to express opsins or 
Designer Receptors Exclusively Activated by Designer Drugs (DREADDS) in specific circuits, 
neuronal populations or glia cells. This approach allows for precise manipulations of circuits and 
cells, either by directly controlling electrical activity (mostly done with optogenetics) or by 
changing signalling pathways in distinct cell types (using DREADDS).63,64 However, one of the 
disadvantages of viral injections is lack of homogeneity, with variable levels of expression and 
targeted regions. There are also potential limitations of using transgenic mice, for example 
positional insertion of transgenes can influence expression levels and a number of Cre mice 
present mosaicism.65 Cre mice may present germ line recombination, causing deletion of floxed 
genes in germ cells, leading to overall deletion of one copy of the gene in all tissues. These 
issues can be mitigated by the careful selection of mouse lines (guidelines for optimal use of Cre 
transgenic lines are provided in ref 66). The use of Cre knockin lines are particularly effective to 
prevent some of these confounds.  
 An important application of using knock-in approaches is the generation of mouse 
models of disease, in which gene mutations similar to the ones found in humans can be inserted 
in a targeted manner into the mouse genome. Alternatively, so-called ‘humanized’ knockin 
mouse models of disease feature modifications of whole mouse genes to match human genes. 
These knock-in approaches provide opportunities for understanding numerous neuropsychiatric 
and neurodegenerative disorders, without the disadvantages of older transgenic approaches (e.g., 
overexpression of gene products). The MouseTRAP platform thus uses knock-in models where 
possible. These models are particularly powerful when combined with cutting-edge 
neurotechnology and touchscreen behavioural testing. Using this combinatorial approach, both 
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genes and cognitive tasks are “humanized”, providing a powerful platform for translational 
understanding.  
 
Combining the use of opsins and fluorescent biosensors with touchscreen-based cognitive 
assessment  
Thanks to the convergent development of optical-based techniques such as 
optogenetics,67,68 fiber photometry69 and miniscopes,70 which each respectively require the use 
of genetically engineered microbial opsins or fluorescent-based biosensors, we are able to 
manipulate and record activity of neural circuits underlying behaviour at a cellular millisecond-
scale resolution while animals freely move around and perform cognitive tests in touchscreens. 
Moreover, because touchscreens can accurately timestamp every significant event during 
training and probe sessions, it is possible to automatically trigger optogenetic stimulation or to 
correlate neural events with behavioural onset/offset, providing mechanistic insights into brain 
diseases. 
Optogenetics is a neurotechnology that combines genetic and optical methods to 
manipulate the activity of discrete population of neurons in living tissue or in behaving 
animals.68 The success of this technology is attributable to several main features: (a) it allows the 
expression of genetically engineered microbial opsins that directly elicit rapid millisecond-scale 
inward or outward electrical currents across cellular membranes in response to pulses of light, 
(b) it may be used to target specific cell populations within the brain, and c) it can be integrated 
with behavioural approaches, including automated touchscreen systems.68 As a result of the 
significant impact of using optogenetic technology in diverse fields in neuroscience and beyond, 
new microbial opsins have been found and genetically engineered to provide a wider spectrum of 
chimeric opsins with different channel kinetics, photocurrent magnitude and spectral 
sensitivity.71,72,73 These recent innovations in optogenetics have increased its suitability to be 
used in combination with fluorescent biosensors (discussed below) to simultaneously record 
neural activity of discrete populations in diverse brain regions. The latter have permitted an ‘all-
optical read-in and read-out’ approach; as optogenetics and fiber photometry/miniscopes use the 
same optical devices to deliver light into discrete brain regions and even share similar TTL-
triggering devices, a researcher can optogenetically stimulate and record neural activity 
simultaneously, which is highly desirable when using touchscreens. 
Understanding the relevant brain network circuitry underlying behaviour is fundamental 
for providing mechanistic insights into brain disease. However, as coordinated spatiotemporal 
firing patterns of neurons (e.g. spike sequence, spike frequency, temporal coding, spike-time 
synchrony) are thought to underlie cognition and learning,74 technologies that can report neural 
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activity at the single-cell resolution while maintaining spatial information are necessary. 
Traditionally, in vivo electrophysiological techniques have been used to record neuronal 
activities at pre- and post-synaptic sites with high temporal resolution, yet while they allow the 
discrimination of heterogeneous populations of cells in discrete brain regions, they cannot be 
used to determine differences in the activity of neuronal subpopulations within those regions. In 
general, technologies that can pinpoint selective and real-time neural circuit dynamics with 
timescales relevant to the formation of behavioural outcomes are required. The development of 
optical tools such as fiber photometry69 and miniscopes70 also has allowed in vivo observation of 
targeted cells and their projections in freely behaving animals. This is a major advantage over the 
method of head-fixing animals to investigate and manipulate neural circuits in vivo, which 
induces physiological stress and reduces an animal’s behavioral repertoire.27 Optical tools have 
become indispensable techniques in neuroscience when used in combination with fluorescent 
biosensors precisely because they allow the activity of selective populations of neurons to be 
correlated with behavioral performance without introducing these types of confounds.75  
Fluorescent biosensors may be divided into two main groups. One group can be used to 
monitor neuronal activity (e.g., calcium, voltage). This kind of biosensor has been applied in 
multiple organisms including rodents, both healthy wild-type and disease models76,77, and 
monkeys.78 Another group of biosensors can be used to detect extracellular neurotransmitters or 
neuromodulators with high sensitivity and specificity.79,80,81,82,83 It is widely known that 
neurotransmitters and neuromodulators play a key role in communication between neurons, and 
are involved in basically all physiological processes, including learning and memory, attention, 
emotion and movement. Neurotransmitter and neuromodulator malfunction is implicated in 
many neurodegenerative and neuropsychiatric diseases, such as the cholinergic system in 
Alzheimer’s Disease84 and the serotoninergic system in depression.85 Optical methods have 
multiple advantages in detecting neuronal signals including: (1) cell-type specificity, when using 
genetically-encoded fluorescent biosensors; (2) high temporal and spatial resolution, which 
permits real-time observation of neuronal signals; and (3) limited damage to samples, especially 
in vivo, compared with traditional methods such as electrophysiological and biochemical 
techniques.  
The MouseTRAP platform combines optical recording plus fluorescent biosensors with 
touchscreen-based cognitive assessment, providing the power to dissect the relationship between 
neuronal activities, neurochemical dynamics, and cognitive behaviors. These tools may be used 
to pinpoint neurochemical and population activity underlying specific stages or aspects of 
cognition with exquisite sensitivity and to identify disruptions in neural circuit activity that 
underlie impairments in behavioral performance in animal models of disease. They thus may 
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provide important insights into which neuronal populations or circuits should be targeted for 
therapeutic intervention in neurodegenerative, neuropsychiatric and other brain disorders. They 
also may be used to determine if acute modulations of neural circuit function produce acute 
changes in behavioral performance in animal models, thus facilitating go-no-go decisions to 
advance drug discovery.86,87,88 MouseTRAP’s emphasis on developing complementary cognitive 
assessment tools for rodents and humans in order to facilitate translation increases the likelihood 
that candidate interventions that are shown to enhance neural circuit function and positively 
impact behavioral performance in animal models of disease will have positive therapeutic 
potential in human patients.  
 
Using computational models to inform analysis of cognitive/behavioral data  
When touchscreens are used in combination with sophisticated technologies for recording 
neuronal activity in vivo during active cognitive processes, a wealth of neural and behavioral 
data is produced, which creates new analytic and interpretative challenges. In order to address 
these challenges and illuminate the relationship between circuit activity and behavior during 
cognitive performance, touchscreen researchers and computational neuroscientists (Muller, 
Mofrad) working within the MouseTRAP platform are collaborating to develop novel techniques 
and models for data analysis. These computational tools will allow rich behavioral data to be 
linked to complex patterns of neural activity at the single-trial and moment-by-moment level and 
permit comparative analyses of circuit and behavioral activity across species, thereby facilitating 
effective translation to clinical application. 
  When analyzing experimental recordings with optical imaging techniques, a key 
consideration is to develop techniques that are robust to noise,89,90 but that also avoid the 
problems of signal attenuation that occur with trial averaging.91,92 By developing and applying 
signal processing techniques that are robust to noise,93 we can identify patterns of neural activity 
associated with cognitive processing, as well as their changes in neurodegenerative and 
neuropsychiatric disease. In addition, connecting these techniques to circuit models enables 
hypothesis-driven investigation of neural circuit dynamics during cognitive tasks in health and 
disease, and these network models can further help with the interpretation of optogenetic 
perturbations. This combined computational modeling and analysis approach can thus connect 
changes in observed brain dynamics to single-neuron and network properties, allowing for the 
identification of mechanisms underlying cognitive deficits and potential targets for therapeutic 
intervention. 
 
Open Science Platforms and Epistemic Community Building   
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A major component of the MouseTRAP philosophy is that revolutionary advances in 
translational research require large-scale collaboration among research teams composed of 
members with diverse training backgrounds and technical expertise. Yet what truly sets 
MouseTRAP apart from other collaborative translational research initiatives is the emphasis its 
researchers place on the importance of pre-publication knowledge and data-sharing practices to 
create a community of scientists who share common methodology and are united in the goals of 
increasing methodological transparency and improving the reliability and reproducibility of 
research findings. In order to foster the development of such a collaborative epistemic 
community surrounding touchscreen use, we have created two open access platforms, 
touchscreencognition.org (Dumont and Ansari) and mousebytes.ca (Memar). As we explain, the 
extensive resources offered on these platforms are unprecedented in rodent behavioral research 
and far exceed information about methods and data typically made available in the methods and 
results sections of published research papers.   
 
Touchscreencognition.org  
Touchscreencognition.org (Figure 1) is a web-based platform for knowledge sharing and 
community building that allows researchers to work collaboratively and troubleshoot common 
problems that may arise when conducting touchscreen based cognitive assessments that 
otherwise may have taken individual research groups more time to solve. Furthermore, more 
individuals working with similar goals in optimizing rodent cognitive testing, developing best 
practices, and enhancing current standardization practices may serve to improve the quality and 
reproducibility of research and ideally lead to greater clinical translation. An additional goal of 
touchscreencognition.org is to provide resources to scientists who have expertise in non-
behavioural areas of neuroscience, ensuring that they can combine their knowledge and 
methodologies with high-quality cognitive testing.  Touchscreencognition.org is available to all 
touchscreen enthusiasts regardless of experience level or type of touchscreen technology used for 
cognitive testing. Indeed, while most researchers on touchscreencognition.org use rodent models, 
a minority of (much welcomed!) researchers study less common animal models (e.g., pigs). 
There are numerous features on the touchscreencognition.org platforms that center on 
community building and knowledge mobilization. First, there is a resource section where 
touchscreen users can gain access to task-specific standard operating procedures (SOPs). The 
resource section also contains training videos with information on how to run an experiment 
beginning with setting up a database to extracting data for upload into MouseBytes.ca (described 
below), training on touchscreen maintenance as well as some “Tips & Tricks” for common 
troubleshooting. This section also includes information on our events (past & present) to join our 
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hands on, in-person, training workshops as well as our annual touchscreen symposium.58 The 
2020 Symposium, including short talks and posters, was conducted virtually and attended by 
scientists from around the world. Most of the talks from graduate students to principal 
investigators are available on the past events section of the site. In addition to these resources, 
more community building features are included. Notably, there is the “Wall” where scientists can 
post their recent touchscreen-related publications, posters, resources, events, and even job 
postings. However, the most interactive portion of the website is the Forum where touchscreen 
users can ask and respond to questions or comment on the latest touchscreen news, tasks, and 
technological upgrades. The active touchscreen community encourages a continued expansion of 
the features found on touchscreencognition.org in order to meet its needs. To stay informed on 
the touchscreen community and changes to touchscreencognition.org, a new quarterly newsletter 
was recently launched, thus furthering the goal of knowledge sharing and expanding the sense of 
community for touchscreen enthusiasts and users.  
 
MouseBytes94  
 To leverage the development of standardized cognitive assessment tools and their 
increased use at multiple research sites, the first ever open-access database (mousebytes.ca)44 for 
rodent translational research was developed by a neuroinformatics specialist (Memar) and 
touchscreen researchers at Western University. It is a fundamental step towards data availability, 
transparency and reproducibility. As Figure 2 shows, the proposed open-access and user-friendly 
repository employs advanced web technologies and connects to a database of cognitive data, 
allowing researchers across the globe to pre-process, run automated quality control scripts on, 
visualize, and analyze their data alone or alongside other researchers’ stored data. A unique link, 
generated for each analysis for sharing the data, can be added to publications for redirecting 
researchers to MouseBytes. Conversely, the DOI of a published manuscript can be linked to 
datasets to facilitate that retrieval from a study. Users can set the status of their data/experiment 
as either private or public in MouseBytes. Data with public status can be shared under CC0 
license, allowing a researcher to reuse, re-analyze and share the data without any restriction. 
Researchers may opt instead to keep their data private, and the accessibility and usage of that 
data will be limited to its owner and those with whom the owner shares that data. Public data in 
MouseBytes are integrated to the analytics TIBCO SPOTFIRE 
(https://www.tibco.com/products/tibco-spotfire) to generate an interactive visualization platform 
for a variety of cognitive tasks. An overview of MouseBytes data, number of labs, principle 
investigators and datasets in the proposed repository can be found at the following link: 
(https://mousebytes.ca/mb-dashboard).  
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Furthermore, expanding mousebytes by incorporating neuroimaging data and recording 
of neural activity in behaving mice, as well as developing algorithms to allow data analysis from 
a variety of species, will facilitate comprehensive multi-modal cognitive analysis to accelerate 
discovery across disease contexts. Combined with another new initiative, PubScreen -- which 
allows interrogation of touchscreen-related outputs using search terms including brain regions, 
neurotransmitters, drugs, techniques, etc. – these open-science tools will help to advance 
knowledge- and data-sharing and improve the understanding of neural mechanisms of brain 
function in health and disease. 
The Circuits to Cognition (C2C) Initiative and Future Directions  
We began this paper with the identification of a set of benchmarks for translational cognitive 
neuroscience research and emphasized that meeting them required collaboration among 
investigators having diverse training backgrounds and complementary technical expertise. In 
addition to our previous research and that currently being undertaken at Western, we have also 
begun an exciting partnership with researchers at McGill University to unite neuroscience 
researchers across these institutions as part of a broader global initiative (Circuits to Cognition; 
C2C) aimed at illuminating the neural mechanisms of cognition and accelerating forward 
translational research. MouseTRAP and a complementary touchscreen-based Open Science 
platform at McGill, the McGill-Mouse-Miniscope (M3) Platform, also described in this special 
issue95 are core components of this initiative.  
What sets the C2C initiative apart is a commitment to integrating standardized touchscreen-based 
cognitive assessment techniques with complementary techniques to investigate neural activity at 
multiple levels of analysis from genes to behavior. Whereas researchers at Western are 
combining genetic techniques and fiber photometry to investigate molecular and neurochemical 
changes in vivo while mice perform touchscreen-based tasks, McGill researchers are combining 
miniscopes with the use of genetically encoded calcium indicators (GECIs) to visualize calcium 
activity in vivo as mice perform touchscreen-based tasks. Just as Western researchers are 
investigating molecular and neurochemical changes in mouse models of disease, McGill 
researchers plan to investigate neuronal population dynamics in mouse models of disease and 
determine abnormal patterns of activity that underlie cognitive deficits in these mouse models. 
The M3 Platform, like MouseTRAP, also functions as a service platform insofar as it provides 
guidelines and technical support for researchers from other institutions to record neuronal 
dynamics in vivo in mice during touchscreen-based tasks and to upload and share their data.  
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Our collaboration with McGill researchers is only the beginning. Given the global rise in 
combining touchscreen technology with state-of-the art neurotechnology and increased 
collaboration among diverse research groups using touchscreens, illuminating the neural 
mechanisms of cognition and identifying novel therapeutics to treat cognitive impairments in 
neuropsychiatric, neurodegenerative and other brain disorders are on the horizon.      
 
List of Rodent Touchscreen 
Tests  
Rat 
(Selected references) 
Mouse 
(Selected references) 
A. Learning and Memory:    
1. Pairwise Visual 
Discrimination Learning 
 
Bussey et al. 1994;23 
Markham et al. 1996;96 
Aggleton et al. 199797  
 
Bussey et al. 2001;25 Brigman 
et al. 200598 
2. Object-Location Paired 
Associates Learning  
Talpos et al., 2009;99 Talpos 
et al. 2014100 
Clelland et al. 2009;101 Bartko 
et al. 2011;102 
Nithianantharajah et al. 
2013;103 
Delotterie et al. 2014;104 Kim 
et al., 2016;105 Whoolery et al. 
2020106 
   
3. Working Memory  
a. Spatial  
1) Trial-Unique 
Nonmatching-to-
Location (TUNL) 
task) 
 
 
2) Continuous Trial 
Unique Nonmatching-
to-Location task 
(cTUNL) 
 
3) Delay Match to 
Position (DNMTP)   
 
b. Non-Spatial  
 
 
Talpos et al. 2010;107 
McAllister et al. 2013108  
 
 
 
 
Hvoslef-Eide et al. 2015;109 
Oomen et al. 2015110 
 
 
 
- 
 
 
 
Bussey et al. 199423 
 
 
Kenton et al. 2018;111 Kim et 
al., 2015112  
 
 
 
 
 
 
 
 
 
Kwak et al. 2015113 
 
 
 
- 
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Non-spatial non-
matching to sample  
 
 
4. Location Discrimination 
(spatial pattern separation) 
 
McTighe et al. 2009114 Clelland et al. 2009;101 Creer et 
al. 2010;115 Coba et al. 2012;116 
Zhou et al. 2016117 
 
5. Spontaneous (Novel) 
Object Recognition 
 
- 
 
Braida et al., 2013;118 Romberg 
et al. 2012119; Reichelt et al.120  
 
6. Visuomotor conditional 
learning (VMCL) 
Bussey et al. 1994;23 Bussey 
et al. 2000;121 Chudasama et 
al. 2001;122 Janisiewicz & 
Baxter 2003123 
 
Delotterie et al. 2014;11 Oren 
Princz-Lebel (2019)124 
7. Automated Search Task 
(AST/ASAT/ Virtual 
Water Maze task) 
Talpos et al., 2008;125 Kumar 
et al. 2015;126 Buscher et al. 
2017127  
 
- 
 
8. Heterogeneous Long 
Sequence Task 
- 
 
 
Kljakic et al. 2020128 
9. Transverse patterning   Bussey et al. 1998129  
10. Category learning Broschard et al. 2020130  
11. Transitive Inference - Sliverman et al. 2015;131 Norris 
et al. 2019132 
 
B. Attention: 
1. 5-choice serial reaction 
time task (5-CSRTT) 
 
Sahgal & Steckler 1994;133 
Steckler & Sahgal 1995;134 
Christakou et al. 2001135 
 
 
Romberg et al. 2011;136 
Kolisnyk et al. 2013137 
2. Continuous Performance 
Test (including Flanker 
task) 
Mar et al. 2017;138 Ding et al. 
2018139 
Kim et al. 2015;140 Hvoslef-
Eide et al. 2018141 
3. 5-choice CPT Braeckman et al., 2019142  - 
 
This article is protected by copyright. All rights reserved.
4. Sustained Attention Task 
(SAT) 
 
Wicks et al. 2017;143 
Bangasser et al. 2017144 
- 
 
5. Spatial Probability Task 
(endogenous) 
- 
 
You & Mysore 2020145  
 
6. Flanker Task (exogenous) 
  
You & Mysore 2020145  
 
7. Posner Cuing Task  Li et al. 2020146 
 
C. Decision Making:   
1. Rodent Gambling Task Cho et al. 2018147 
 
Humby et al. 2020;148 Palmer 
(unpublished)149 
 
2. Risky Decision-Making 
Task (RDT) 
 
- Glover et al. 2020150 
3. Delay Discounting Abela & Chudasama 2013,151 
2014152 
 
Ben U Phillips 
(unpublished)153 
4. Probability Discounting Abela & Chudasama 2013151  - 
5. Effort-related 
Choice/Decision 
 
- 
 
Heath et al. 2015;154 Yang et 
al. 2020155 
6. Effort-related Discounting 
(three versions including 
Rearing-Effort 
Discounting (RED) Task)  
- Lopez-Cruz et al. 2017156 
 
7. Fixed Ratio Discounting 
 
- 
 
Lopez-Cruz et al. 2017156  
 
D. Cognitive Flexibility and 
Response Inhibition: 
1. Reversal learning 
 
 
Bussey et al. 1997;157 
Chudasama et al. 2001;122 
Chudasama & Robbins 
2003158 
 
 
 
Brigman et al. 2006;159 
Izquierdo et al. 2006;160 
Piantadosi et al. 2018161  
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2. ID/ED Set-shifting Brigman et al. 2005,98 
2006;162 Dickson et al. 
2014,163 2016164 
 
McAllister 2012165 
3. Extinction Learning 
(response to omission of 
reward) 
Dalley et al. 2002;166  
Chudasama & Robbins 
2003158  
 
Brigman et al. 2008;167 Hefner 
et al. 2008;168 Lederle et al. 
2011169 
4. Contextual Rule Switching Ahn & Lee 2014170 Rutz & Rothblat 2012171 
5. The STABFLEX task  - Richter et al. 2014172  
 
E. Emotional cognition and 
responding to reinforcement: 
  
1. Progressive Ratio Test of 
Motivation/Apathy 
 
Hailwood et al. 2018173 Heath et al. 2015;154 Phillips et 
al. 2017174 
 
2. Response to Negative (and 
Positive) Feedback (spatial 
and nonspatial; 
probabilistic and 
deterministic learning and 
reversal learning 
 
 
Wilkinson et al., 2020175 
 
Phillips et al. 2018176 
3. Autoshaping (Pavlovian 
approach to reward; sign- 
and goal-tracking;  
 
Bussey et al. 1997;157 Inglis et 
al. 2000;177 Parkinson et al. 
2000;178 Dalley et al. 2005179 
Nithianantharajah et al. 2013103 
4. Cognitive Judgement Bias 
(optimism/pessimism) 
 Krakenberg et al. 2019180 
Table 1. Some available touchscreen-based tests for use with rats and/or mice, with selected 
references. The list of tasks is not exhaustive, nor is the list of references for each task. The table 
is organized by cognitive construct, but in many cases, tasks can be used to study multiple 
constructs, via manipulation of parameters that load on different constructs (for example the 5-
CSRTT is used to study attention and also cognitive flexibility/impulsivity).  
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Figure 1.The touchscreencognition.org virtual space. Clockwise from left, (1) The main page for 
touchscreencognition.org, containing links to different parts of the site including the training 
sessions we offer and how to set up a user account; (2) the Wall, where contributors may share 
recently published or presented touchscreen related research; (3) the Forums page, where 
touchscreen users can post touchscreen related questions and receive responses from the global 
touchscreen community; (4) A global map representing all of the laboratories worldwide that use 
rodent touchscreens. (5) Information about funding support for the site as well as a link to 
@TouchScreenCog’s Twitter feed.  
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Figure 2. MouseBytes Data Integration and Sharing Flow Diagram: Uploading cognitive 
behavioral data is followed by quality control in order to transfer valid and complete data into the 
database. Public data can be searched based on different search criteria and shared using the 
generated unique URL. Public data in the database are also integrated with their MRI data and 
sensor data from fiber photometry to increase the functionality and use of MouseBytes and 
facilitate multimodality data integration and analysis.  
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